150 related articles for article (PubMed ID: 27010626)
1. The Cost of Facial Deformity: A Health Utility and Valuation Study.
Dey JK; Ishii LE; Joseph AW; Goines J; Byrne PJ; Boahene KD; Ishii M
JAMA Facial Plast Surg; 2016 Jul; 18(4):241-9. PubMed ID: 27010626
[TBL] [Abstract][Full Text] [Related]
2. Societal Value of Surgery for Facial Reanimation.
Su P; Ishii LE; Joseph A; Nellis J; Dey J; Bater K; Byrne PJ; Boahene KD; Ishii M
JAMA Facial Plast Surg; 2017 Mar; 19(2):139-146. PubMed ID: 27892977
[TBL] [Abstract][Full Text] [Related]
3. The Health Utility and Valuation of Cosmetic Rhinoplasty.
Kumar AR; Ishii M; Papel I; Kontis T; Liao D; Chen J; Ishii LE
Facial Plast Surg Aesthet Med; 2020; 22(4):268-273. PubMed ID: 32282229
[No Abstract] [Full Text] [Related]
4. Measuring Outcomes of Mohs Defect Reconstruction Using Eye-Tracking Technology.
Dey JK; Ishii LE; Boahene KDO; Byrne PJ; Ishii M
JAMA Facial Plast Surg; 2019 Dec; 21(6):518-525. PubMed ID: 31670742
[TBL] [Abstract][Full Text] [Related]
5. The social penalty of facial lesions: new evidence supporting high-quality reconstruction.
Dey JK; Ishii LE; Byrne PJ; Boahene KD; Ishii M
JAMA Facial Plast Surg; 2015; 17(2):90-6. PubMed ID: 25474194
[TBL] [Abstract][Full Text] [Related]
6. Impact of facial defect reconstruction on attractiveness and negative facial perception.
Dey JK; Ishii M; Boahene KD; Byrne P; Ishii LE
Laryngoscope; 2015 Jun; 125(6):1316-21. PubMed ID: 25647278
[TBL] [Abstract][Full Text] [Related]
7. Visual Attention to Facial Defects Predicts Willingness to Pay for Reconstructive Surgery.
Ryan JF; Ishii LE; Dey JK; Boahene KDO; Byrne PJ; Ishii M
Facial Plast Surg Aesthet Med; 2022; 24(6):436-442. PubMed ID: 35404137
[No Abstract] [Full Text] [Related]
8. Measurement of the Quality of Facial Lesion Reconstruction With Observer-Graded Affect Display.
Phillis M; Ishii M; Dey J; Goines J; Byrne PJ; Boahene KD; Ishii LE
JAMA Facial Plast Surg; 2016 Dec; 18(6):467-473. PubMed ID: 27466981
[TBL] [Abstract][Full Text] [Related]
9. Comparing Patient, Casual Observer, and Expert Perception of Permanent Unilateral Facial Paralysis.
Dey JK; Ishii LE; Nellis JC; Boahene KDO; Byrne PJ; Ishii M
JAMA Facial Plast Surg; 2017 Dec; 19(6):476-483. PubMed ID: 28056121
[TBL] [Abstract][Full Text] [Related]
10. A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population.
Mavrodi A; Aletras V
Value Health Reg Issues; 2020 Sep; 22():36-43. PubMed ID: 32731168
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
Nimdet K; Chaiyakunapruk N; Vichansavakul K; Ngorsuraches S
PLoS One; 2015; 10(4):e0122760. PubMed ID: 25855971
[TBL] [Abstract][Full Text] [Related]
12. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.
Lieu TA; Ray GT; Ortega-Sanchez IR; Kleinman K; Rusinak D; Prosser LA
Pharmacoeconomics; 2009; 27(12):1005-16. PubMed ID: 19908925
[TBL] [Abstract][Full Text] [Related]
13. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.
Nimdet K; Ngorsuraches S
BMJ Open; 2015 Oct; 5(10):e008123. PubMed ID: 26438135
[TBL] [Abstract][Full Text] [Related]
14. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
King JT; Tsevat J; Lave JR; Roberts MS
Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of willingness to pay per quality-adjusted life year for a cure: A contingent valuation method using a scenario-based survey.
Song HJ; Lee EK
Medicine (Baltimore); 2018 Sep; 97(38):e12453. PubMed ID: 30235732
[TBL] [Abstract][Full Text] [Related]
16. Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec.
Kouakou CRC; He J; Poder TG
Eur J Health Econ; 2024 Jul; 25(5):787-811. PubMed ID: 37656261
[TBL] [Abstract][Full Text] [Related]
17. Willingness to Pay for a Quality-Adjusted Life Year among Gastrointestinal Cancer Patients at a Tertiary Hospital of Vietnam, 2022.
Tran BT; Tran TT; La NQ; Nguyen TTP; Nguyen MH; Huynh TMC; Vu HP
Asian Pac J Cancer Prev; 2024 May; 25(5):1725-1735. PubMed ID: 38809645
[TBL] [Abstract][Full Text] [Related]
18. Willingness to pay for a quality-adjusted life-year: the individual perspective.
Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of process utility: elucidating preferences for a non-invasive procedure to treat restenosis.
Aviles-Blanco MV
Health Econ Rev; 2021 Jul; 11(1):27. PubMed ID: 34297212
[TBL] [Abstract][Full Text] [Related]
20. Willingness to pay for a QALY: theoretical and methodological issues.
Gyrd-Hansen D
Pharmacoeconomics; 2005; 23(5):423-32. PubMed ID: 15896094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
